Table 2.
HPV vaccine uptake and associated characteristics of respondents (N = 108)
| Baseline |
Follow-Up |
||
|---|---|---|---|
| Characteristic | No. (%) | No. (%) | p valuea |
| HPV Vaccine (≥1 dose) | <0.001 | ||
| Yes | 36 (33.3) | 59 (54.6) | |
| No | 72 (66.7) | 49 (45.4) | |
| Healthcare Provider Recommended HPV Vaccine | 0.700 | ||
| Yes | 71 (65.7) | 70 (64.8) | |
| No | 18 (16.7) | 14 (13.0) | |
| Unknown | 19 (17.6) | 24 (22.2) | |
| Discussed HPV Vaccine with Parents | 0.744 | ||
| Yes | 56 (51.8) | 60 (55.6) | |
| No | 46 (42.6) | 40 (37.0) | |
| Unknown | 6 (5.6) | 8 (7.4) | |
| Trusted Sources of Information on HPV Vaccine | -- | ||
| Healthcare Providers | N/A | 88 (81.5) | |
| Family | N/A | 59 (54.6) | |
| Internet | N/A | 45 (41.7) | |
| Books/Printed Literature | N/A | 19 (17.6) | |
| Teachers/School | N/A | 10 (9.3) | |
| Other (friends, church, TV, radio, etc.) | N/A | 17 (15.7) |
No = frequency; % = percentage; HPV = human papillomavirus; N/A = not available.
a
P values were derived using McNemar's test.